-
"It will contribute to the attainment of Universal Health Coverage through comprehensive HIV prevention, treatment and care," read a statement by MoH.
-
Additionally, it will reduce malaria incidence and deaths by at least 75 per cent by 2027.
Image: FILE
Kenya has signed four global fund grants amounting to Sh59.7 billion ($407,989,068).
A joint statement released by the Ministry of Health and the Global Fund said that the funds will support HIV, TB and malaria intervention and strengthen health and community systems.
The total amounts for each grant include; an HIV grant of $232,580,654, malaria grant $72,934,665, TB grant U$67,785,529 and health systems strengthening $34,688,220
The new global fund will support the provision of quality care and prevention services for all people with TB, leprosy and lung diseases.
"It will contribute to the attainment of Universal Health Coverage through comprehensive HIV prevention, treatment and care," the statement read.
Additionally, it will reduce malaria incidence and deaths by at least 75 per cent by 2027.
It further aims at the strengthening of Health systems at the facility and community level.
"The global fund will aim to support the procurement of TB, Malaria and HIV commodities including medicines, laboratory supplies and test kits," it read.
It will seek to support primary healthcare activities at the community level in line with the Universal Health Care agenda.
The fund will also serve to facilitate social support and Social Health Insurance Fund premiums for TB/HIV/Malaria patients to access a full SHIF benefit package.
The Global Fund is a partnership between governments, civil society, the private sector and people affected by diseases designed to accelerate the end of AIDS, Tuberculosis and Malaria epidemics globally.
In HIV, the Global Fund has supported the procurement of commodities like antiretrovirals (ARVs), HIV test kits, condoms and laboratory reagents.
"For the TB programme, we have recorded a treatment success rate of 86 per cent with average positivity rate among TB presumptive cases declined from 7.35 per cent in 2021 to 5.6 per cent in March 2024 while the absolute number tested more than doubled from 245,902 in 2021 to 502,970 in March 2024," it added.
The statement read that the Global Fund has further partnered with the government to provide support for the establishment of 1,933 community health units, training of 18,500 community health promotors CHPS and 3,700 Community Health Extension Workers (CHEWs).
"The Malaria programme has contributed to the overall reduction of malaria burden in Kenya, with the national level prevalence declining from 8.2 per cent in 2015 to 6 per cent in 2023," the statement read.
It added that in partnership with the government, the Global Fund has invested US$ 9.5 m in the construction, equipping and digitisation of Kemsa National Supply Chain Centre.
"This investment will enhance supply chain, support service delivery at Primary Health Care and with adequate storage, strengthen responses to pandemics and emergencies resulting from climate change," it read.
It further noted that this kind of investment is a good example of multi-partner investment over some time.
"Building resilient systems takes a lot of time and resilience.KEMSA, Development Partners and other stakeholders should be congratulated for achieving this milestone," it read.